Mohammad Abu Faisal

Lean MAFLD and MASLD represent an underrecognized high risk phenotype beyond body mass index

Metabolic dysfunction-associated fatty liver disease (MAFLD) and the more recently proposed metabolic dysfunction-associated steatotic liver disease (MASLD) represent diagnostic frameworks evolving from non-alcoholic fatty liver disease (NAFLD), highlighting a greater emphasis on underlying metabolic dysfunction. Both...